Unmet needs in desmoid tumors

6 Views
administrator
administrator
07/04/23

Robin Jones, MBBS, MRCP, MD, The Royal Marsden NHS Foundation Trust, London, UK, discusses unmet needs in the treatment of desmoid tumors and how the Phase II/III RINGSIDE trial (NCT04871282) could introduce a new treatment option for these patients. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next